Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
2 Top Biotech Stocks With Huge Potential
11:31am, Saturday, 12'th Mar 2022
Below stocks have been added to my watchlist.
Got $5,000? 3 Growth Stocks to Buy That Could Double Your Money
10:45am, Saturday, 12'th Mar 2022
They have a whole lot going right, and little in the way of obstacles.
2 Top Biotech Stocks Ready for a Bull Run
12:34pm, Wednesday, 09'th Mar 2022 The Motley Fool
With more to their businesses than COVID-19 revenue, these two companies have huge market opportunities ahead.
2 Top Biotech Stocks Ready for a Bull Run
07:34am, Wednesday, 09'th Mar 2022
With more to their businesses than COVID-19 revenue, these two companies have huge market opportunities ahead.
Fulgent Genetics stock gains on $250M share buyback program (NASDAQ:FLGT)
01:08pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Fulgent Genetics (FLGT) is +4.31% pre-market after announcing a share repurchase program under which it may buyback $250M of its common stock.The program will be funded using…
Trying to Time the Market Doesn't Work
09:35pm, Friday, 04'th Mar 2022 The Motley Fool
Plus a look at market news and an interview with The Trade Desk CEO Jeff Green.
Trying to Time the Market Doesn't Work
04:35pm, Friday, 04'th Mar 2022
Plus a look at market news and an interview with The Trade Desk CEO Jeff Green.
Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
02:21pm, Sunday, 27'th Feb 2022 Seeking AlphaFulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
09:21am, Sunday, 27'th Feb 2022
Once again, the company exceeded quarterly expectations on the flare-up of another pandemic wave.
Fulgent, Epic Sciences collaborate on test for metastatic breast cancer
05:07pm, Thursday, 24'th Feb 2022 Seeking Alpha
Epic Sciences is collaborating with Fulgent Genetics (FLGT) to deliver DefineMBC comprehensive profiling results for patients with metastatic breast cancer ((MBC)).The partnership…
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
01:01pm, Thursday, 24'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Adagio Appoints COO David Hering As Interim CEO
Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced th
Fulgent Genetics, Inc. (FLGT) Q4 2021 Earnings Call Transcript
04:00am, Thursday, 24'th Feb 2022 The Motley Fool
FLGT earnings call for the period ending December 31, 2021.
Fulgent Genetics, Inc. (FLGT) Q4 2021 Earnings Call Transcript
04:00am, Thursday, 24'th Feb 2022 The Motley Fool
FLGT earnings call for the period ending December 31, 2021.
Fullgent Genetics (FLGT) Q4 Earnings and Revenues Surpass Estimates
11:15pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Fullgent Genetics (FLGT) delivered earnings and revenue surprises of 25.56% and 31.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
